Rigel Pharmaceuticals | RIGL - Kapitalizacja Rynkowa





Kapitalizacja Rynkowa Zmiana Data
Agenus USD 107M 16M 2025-12
Amgen USD 189.89B 13.64B 2026-03
Anika Therapeutics USD 139M 3M 2025-12
Arrowhead Research USD 8.78B 236M 2026-03
AstraZeneca USD 301.25B 13.1B 2026-03
BioMarin Pharmaceutical USD 10.86B 553M 2026-03
Bristol-Myers Squibb USD 123.83B 14.02B 2026-03
Celldex Therapeutics USD 2.11B 307M 2026-03
Eli Lilly USD 869.02B 146.97B 2026-03
Halozyme Therapeutics USD 7.66B 257M 2026-03
Heron Therapeutics USD 238M 7M 2025-12
Ionis Pharmaceuticals USD 12.46B 356M 2026-03
Karyopharm Therapeutics USD 1.05B 912M 2026-06
Ligand Pharmaceuticals USD 3.98B 241M 2026-03
Neurocrine Biosciences USD 13.25B 890M 2026-03
Pfizer USD 153.81B 12.24B 2026-03
Regeneron Pharmaceuticals USD 81.68B 560M 2026-03
Ultragenyx Pharmaceutical USD 2.06B 159M 2026-03
Veracyte USD 2.57B 758M 2026-03